Are you Dr. Hwu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 64 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Wen-Jen Hwu, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, New York, and Connecticut. She is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1988
University of California (Irvine)Residency, Internal Medicine, 1982 - 1985
University of California, Irvine, School of MedicineClass of 1982
Certifications & Licensure
CA State Medical License 1983 - 2024
TX State Medical License 2005 - 2018
CT State Medical License 1984 - 2009
NY State Medical License 1988 - 2008- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma Start of enrollment: 1999 Dec 01
- Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma Start of enrollment: 2001 May 01
- Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma Start of enrollment: 2003 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 189 citationsGut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.Miles C. Andrews, Connie P.M. Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, Wei Shen Chen, Lisa Derosa, Abdul Wadud Khan, Alexandria P. Cogdill, Michael G. White,...> ;Nature Medicine. 2021 Jul 8
- 48 citationsLong-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma., , , , , , , , , , , , , , , , , , , , , > ;European Journal of Cancer. 2021 Feb 1
- 4 citationsPrognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.Haider A. Mejbel, Carlos A. Torres-Cabala, Denái R. Milton, Doina Ivan, Priyadharsini Nagarajan, Jonathan L. Curry, Ana M. Ciurea, Adam I. Rubin, Wen-Jen Hwu, Victor G...> ;Archives of Pathology & Laboratory Medicine. 2021 Aug 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
